Login / Signup

Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma.

Qiuyun YuanWanchun YangShuxin ZhangTengfei LiMingrong ZuoXingwang ZhouJunhong LiMao LiXiaoqiang XiaMina ChenYanhui Liu
Published in: Molecular medicine (Cambridge, Mass.) (2021)
Our work establishes the relationship between MTCH2 expression and glioma malignancy, and provides a potential target for future interventions.
Keyphrases
  • poor prognosis
  • oxidative stress
  • physical activity
  • signaling pathway
  • newly diagnosed
  • human health
  • long non coding rna
  • climate change